{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:48:50Z","timestamp":1789602530720,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Noonan syndrome (NS) is a clinically and genetically heterogeneous disorder. Since its clinical phenotype is often mild and difficult to differentiate from other syndromes, its diagnosis can be challenging and its prevalence in the pediatric population is most certainly underestimated. The difficulty in identifying Noonan syndrome is also increased by the fact that genetic tests are currently not able to detect an underlying mutation in around 10% of the cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective, observational study conducted at the Institute for Maternal and Child \u201cBurlo Garofolo\u201d in Trieste, Italy. We recruited all the patients with clinical and\/or genetic diagnosis of NS who were evaluated at the Department of Pediatrics between October 2015 and October 2020. Statistical analyses were performed with IBM SPSS Statistics software. The association between discrete variables has been evaluated through chi-squared test, indicating statistically significant p with Pearson test or Fischer test for variables less than 5.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We recruited a total of 35 patients affected by Noonan syndrome. In 24 patients (75%) we identified an underlying genetic substrate: 17 patients had a mutation on PTPN11 (61%), 2 in SOS1, KRAS and SHOC2 (7% each) and only 1 in RAF1 (4%). 25% of the subjects did not receive a genetic confirm. As for the phenotype of the syndrome, our study identified the presence of some clinical features which were previously unrelated or poorly related to NS. For example, renal and central nervous system abnormalities were found at a higher rate compared to the current literature. On the contrary, some features that are considered very suggestive of NS (such as lymphatic abnormalities and the classical facial features) were not frequently found in our population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In our analysis, we focused on the main phenotypic features of NS, identifying various clinical manifestation that were not associated with this genetic condition before. This could be helpful in raising the knowledge of NS\u2019s clinical spectrum, facilitating its diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03804-2","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T07:02:36Z","timestamp":1671865356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["New insights on Noonan syndrome\u2019s clinical phenotype: a single center retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Francesco","family":"Baldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Fachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Da Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Rubinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Barbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"issue":"2","key":"3804_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-2-4","volume":"14","author":"I Van der Burgt","year":"2007","unstructured":"Van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007;14(2):4.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3804_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19(3):230\u20136.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"3804_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I","volume":"94","author":"I Van Der Burgt","year":"2000","unstructured":"Van Der Burgt I, Brunner H. Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form. Am J Med Genet. 2000;94(1):46\u201351.","journal-title":"Am J Med Genet"},{"issue":"1","key":"3804_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25(1):161\u201379.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"3804_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","volume":"20","author":"JJ Johnston","year":"2018","unstructured":"Johnston JJ, van der Smagt JJ, et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet Med. 2018;20(10):1175\u201385.","journal-title":"Genet Med"},{"issue":"1","key":"3804_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61(1):33\u20139.","journal-title":"J Hum Genet"},{"issue":"2","key":"3804_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ajmg.1320530213","volume":"53","author":"I Van der Burgt","year":"1994","unstructured":"Van der Burgt I, Berends E, Lommen E, et al. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994;53(2):187\u201391.","journal-title":"Am J Med Genet"},{"issue":"8","key":"3804_CR8","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/ajmg.a.33518","volume":"152A","author":"JE Allanson","year":"2010","unstructured":"Allanson JE, Bohring A, D\u00f6rr HG, Dufke A, Gillessen-Kaesbach G, Horn D, et al. The face of Noonan syndrome: does phenotype predict genotype. Am J Med Genet A. 2010;152A(8):1960\u20136.","journal-title":"Am J Med Genet A"},{"issue":"Suppl 2","key":"3804_CR9","first-page":"31","volume":"72","author":"BJ Otten","year":"2009","unstructured":"Otten BJ, Noordam C. Growth in Noonan syndrome. Horm Res. 2009;72(Suppl 2):31\u20135.","journal-title":"Horm Res"},{"issue":"5","key":"3804_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1530\/EJE-15-0922","volume":"174","author":"C Cessans","year":"2016","unstructured":"Cessans C, Ehlinger V, Arnaud C, Yart A, Capri Y, Barat P, et al. Growth patterns of patients with Noonan syndrome: correlation with age and genotype. Eur J Endocrinol. 2016;174(5):641\u201350.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"3804_CR11","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1210\/jc.2005-0995","volume":"90","author":"G Binder","year":"2005","unstructured":"Binder G, Neuer K, Ranke MB, Wittekindt NE. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome. J Clin Endocrinol Metab. 2005;90(9):5377\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3804_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MOP.0000000000000669","volume":"30","author":"ME Pierpont","year":"2018","unstructured":"Pierpont ME, Digilio MC. Cardiovascular disease in Noonan syndrome. Curr Opin Pediatr. 2018;30(5):601\u20138.","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"3804_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14348\/molcells.2019.0037","volume":"42","author":"YE Kim","year":"2019","unstructured":"Kim YE, Baek ST. Neurodevelopmental aspects of RASopathies. Mol Cells. 2019;42(6):441\u20137.","journal-title":"Mol Cells"},{"issue":"2","key":"3804_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/adc.67.2.178","volume":"67","author":"M Sharland","year":"1992","unstructured":"Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67(2):178\u201383.","journal-title":"Arch Dis Child"},{"issue":"11","key":"3804_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1515\/JPEM.2008.21.11.1079","volume":"21","author":"KA Marcus","year":"2008","unstructured":"Marcus KA, Sweep CG, van der Burgt I, Noordam C. Impaired Sertoli cell function in males diagnosed with Noonan syndrome. J Pediatr Endocrinol Metab. 2008;21(11):1079\u201384.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"3804_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000517605","volume":"13","author":"J Sleutjes","year":"2022","unstructured":"Sleutjes J, Kleimeier L, Leenders E, Klein W, Draaisma J. Lymphatic abnormalities in Noonan syndrome Spectrum disorders: a systematic review. Mol Syndromol. 2022;13(1):1\u20131.","journal-title":"Mol Syndromol"},{"issue":"2","key":"3804_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/01443610410001648386","volume":"24","author":"SV Gandhi","year":"2004","unstructured":"Gandhi SV, Howarth ES, Krarup KC, Konje JC. Noonan syndrome presenting with transient cystic hygroma. J Obstet Gynaecol. 2004;24(2):183\u20134.","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"3804_CR18","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","volume":"133","author":"A Artoni","year":"2014","unstructured":"Artoni A, Selicorni A, Passamonti SM, Lecchi A, Bucciarelli P, Cerutti M, et al. Hemostatic abnormalities in Noonan syndrome. Pediatrics. 2014;133(5):e1299\u2013304.","journal-title":"Pediatrics."},{"key":"3804_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0140-6736(92)90141-O","volume":"339","author":"M Sharland","year":"1992","unstructured":"Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH. Coagulation-factor deficiencies and abnormal bleeding in Noonan\u2019s syndrome. Lancet. 1992;339:19\u201321.","journal-title":"Lancet."},{"issue":"2","key":"3804_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34(2):148\u201350.","journal-title":"Nat Genet"},{"issue":"8","key":"3804_CR21","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/bjc.2015.75","volume":"112","author":"CP Kratz","year":"2015","unstructured":"Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, et al. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer. 2015;112(8):1392\u20137.","journal-title":"Br J Cancer"},{"issue":"9863","key":"3804_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;381(9863):333\u201342.","journal-title":"Lancet."},{"key":"3804_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijporl.2017.04.024","volume":"97","author":"JWI Van Nierop","year":"2017","unstructured":"Van Nierop JWI, van Trier DC, van der Burgt I, Draaisma JMT, Mylanus EAM, Snik AF, et al. Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11. Int J Pediatr Otorhinolaryngol. 2017;97:228\u201334.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"8","key":"3804_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6061\/clinics\/2013(08)03","volume":"68","author":"CR Quaio","year":"2013","unstructured":"Quaio CR, de Almeida TF, Brasil AS, Pereira AC, Jorge AA, Malaquias AC, et al. Tegumentary manifestations of Noonan and Noonan-related syndromes. Clinics (Sao Paulo, Brazil). 2013;68(8):1079\u201383.","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"3804_CR25","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1136\/jmg.2003.013466","volume":"41","author":"A Sarkozy","year":"2004","unstructured":"Sarkozy A, Conti E, Digilio MC, et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet. 2004;41:e68.","journal-title":"J Med Genet"},{"issue":"9","key":"3804_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet. 2009;41(9):1022\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"3804_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/341528","volume":"71","author":"MC Digilio","year":"2002","unstructured":"Digilio MC, Conti E, Sarkozy A, et al. Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002;71(2):389\u201394.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"3804_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/BF02010926","volume":"23","author":"CD George","year":"1993","unstructured":"George CD, Patton MA, el Sawi M, et al. Abdominal ultrasound in Noonan syndrome: a study of 44 patients. Pediatr Radiol. 1993;23(4):316\u20138.","journal-title":"Pediatr Radiol"},{"issue":"11","key":"3804_CR29","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/ajmg.a.36737","volume":"164A","author":"A Myers","year":"2014","unstructured":"Myers A, Bernstein JA, Brennan ML, Curry C, Esplin ED, Fisher J, et al. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome. Am J Med Genet A. 2014;164A(11):2814\u201321.","journal-title":"Am J Med Genet A"},{"key":"3804_CR30","first-page":"408","volume":"60","author":"I Ejarque","year":"2015","unstructured":"Ejarque I, Mill\u00e1n-Salvador JM, Oltra S, Pesudo-Mart\u00ednez JV, Beneyto M, P\u00e9rez-Ayt\u00e9s A. Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS\/MAPK pathway. Rev Neurol. 2015;60:408\u201312.","journal-title":"Rev Neurol"},{"key":"3804_CR31","doi-asserted-by":"crossref","unstructured":"Zarate YA, Lichty AW, Champion KJ, Clarkson LK, Holden KR, Matheus MG. Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation. J Child Neurol 2014;29:NP13\u20137.","DOI":"10.1177\/0883073813492384"},{"key":"3804_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/2152-7806.125546","volume":"5","author":"T Mitsuhara","year":"2014","unstructured":"Mitsuhara T, Yamaguchi S, Takeda M, Kurisu K. Gowers' intrasyringeal hemorrhage associated with Chiari type I malformation in Noonan syndrome. Surg Neurol Int. 2014;5:6.","journal-title":"Surg Neurol Int"},{"key":"3804_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00381-012-2000-9","volume":"29","author":"YS Keh","year":"2013","unstructured":"Keh YS, Abernethy L, Pettorini B. Association between Noonan syndrome and Chiari I malformation: a case-based update. Childs Nerv Syst. 2013;29:749\u201352.","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"3804_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.seizure.2011.07.013","volume":"21","author":"M Adachi","year":"2012","unstructured":"Adachi M, Abe Y, Aoki Y, Matsubara Y. Epilepsy in RAS\/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review. Seizure. 2012;21(1):55\u201360.","journal-title":"Seizure."},{"issue":"5","key":"3804_CR35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ejhg.2015.175","volume":"24","author":"S Joyce","year":"2016","unstructured":"Joyce S, Gordon K, Brice G, Ostergaard P, Nagaraja R, Short J, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. Eur J Hum Genet. 2016;24(5):690\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"3804_CR36","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00431-008-0670-9","volume":"167","author":"R Raaijmakers","year":"2008","unstructured":"Raaijmakers R, Noordam C, Noonan JA, Croonen EA, van der Burgt CJ, Draaisma JM. Are ECG abnormalities in Noonan syndrome characteristic for the syndrome? Eur J Pediatr. 2008;167(12):1363\u20137.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03804-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T14:13:30Z","timestamp":1672236810000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03804-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03804-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the Institute of Maternal and Child Health, \u201cIRCCS Burlo Garofolo\u201d, Trieste (Italy). All methods were carried out in accordance with relevant guidelines and regulations. As for the genetics analysis, informed consent to the analysis was obtained from all subjects and\/or their legal guardian(s) for minors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Francesco Baldo declares that he has no conflict of interest. Alice Fachin declares that she has no conflict of interest. Beatrice Da Re declares that she has no conflict of interest. Elisa Rubinato declares that she has no conflict of interest. Marco Bobbo declares that he has no conflict of interest. Egidio Barbi declares that he has no conflict of interest","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"734"}}